SFA — Sopharma AD Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeMid CapTurnaround

Annual balance sheet for Sopharma AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	25.1	37.7	19.9	129	36
Net Total Accounts Receivable
Net Total Receivables	282	253	247	290	326
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	612	571	572	787	851
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	396	362	376	358	391
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,242	1,205	1,254	1,514	1,800
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	544	424	407	609	726
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	689	558	549	776	976
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Total Equity	553	647	705	738	824
Total Liabilities & Shareholders' Equity	1,242	1,205	1,254	1,514	1,800
Total Common Shares Outstanding